Lung Archives - Oncology Today

Lung

RYBREVANT®▼ (amivantamab) with LAZCLUZE™▼ (lazertinib) is accepted for use within NHS Scotland as a first-line treatment for adult patients with untreated advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations

by Catherine Bontoft

11 May 2026

Lung

NICE issues Final Draft Guidance recommending that RYBREVANT®▼(amivantamab) with carboplatin and pemetrexed can be used during a managed access period for untreated advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 20 insertion mutations in adult

8 May 2026

Lung

NHS first as Barts patient treated with new surgical robot

15 April 2026

Lung

Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives

27 March 2026

Lung

Oncology News Today brings you all the latest news and developments in the world of lung cancer

Lung

RYBREVANT®▼ (amivantamab) with LAZCLUZE™▼ (lazertinib) is accepted for use within NHS Scotland as a first-line treatment for adult patients with untreated advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations

by Catherine Bontoft

11 May 2026

Johnson & Johnson welcomes the decision made today by the Scottish Medicines Consortium (SMC) to accept RYBREVANT®▼ (amivantamab) with LAZCLUZE™▼...

Lung

NICE issues Final Draft Guidance recommending that RYBREVANT®▼(amivantamab) with carboplatin and pemetrexed can be used during a managed access period for untreated advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) exon 20 insertion mutations in adult

by Catherine Bontoft

8 May 2026

Johnson & Johnson is pleased to announce today that the National Institute for Health and Care Excellence (NICE) has recommended...

Lung

NHS first as Barts patient treated with new surgical robot

by Catherine Bontoft

15 April 2026

A patient at Barts Health NHS Trust is the first in the NHS to have lung cancer surgery using the...

Lung

Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives

by Catherine Bontoft

27 March 2026

A new research paper in Nature Medicine shows screening for lung cancer dramatically increases early-stage detection, particularly in socioeconomically deprived...

Experience, education and data garnered by the pioneering Prehab4Cancer (P4C) programme in Greater Manchester has helped to shape national guidelines on cancer care adopted by the NHS and Macmillan Cancer Support.

Colorectal

National recognition for Prehab4Cancer as it launches education initiative for leisure centre staff

by Catherine Bontoft

9 February 2026

Experience, education and data garnered by the pioneering Prehab4Cancer (P4C) programme in Greater Manchester has helped to shape national guidelines...

Dr Adam Januszewski, Consultant Medical Oncologist at Barts Health NHS Trust

Lung

Opdivo® (nivolumab) with chemotherapy before surgery then alone after surgery recommended for use on the NHS when treating adult patients with resectable NSCLC

by Catherine Bontoft

28 January 2026

Nivolumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) has been recommended by the National Institute for Health...

Register today to gain access to all of our articles

To gain access to our entire site, simply click the button below and register.

NHS first as Barts patient treated with new surgical robot

Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives

Lung

NHS first as Barts patient treated with new surgical robot

Research paper shows screening for lung cancer dramatically increases early-stage detection, helping to save lives

National recognition for Prehab4Cancer as it launches education initiative for leisure centre staff

Opdivo® (nivolumab) with chemotherapy before surgery then alone after surgery recommended for use on the NHS when treating adult patients with resectable NSCLC

Register today to gain access to all of our articles

Sign up to receive our free monthly newsletter

Are you a healthcare professional?